Reduced cellular glucose uptake in response to insulin and decreased expression of a mitochondrial ETC complex subunit in <i>ALAS1</i>-knockdown C2C12 myocytes. by Shinichi Saitoh (4794345)

Analysis of ATP1A1 protein expression, blood pressure, heart rate and activity in heterozygous <i>ATP1A1^+/−</i> and wild-type male mice. by Victoria L. Herrera (383897)

“…(E) Mean activity ± sem (Counts/min) in <i>ATP1A1^+/−</i> (solid bars, n = 4) and wild-type (open bars, n = 5) male mice. * <i>P</i> < 0.03, ** <i>P</i> = 0.015 (two-tailed student <i>t</i>-test).…”

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

rAd-p53 induces apoptosis in HCC cell lines with increased Fbxw7 and decreased c-Myc and Cyclin E. by Kangsheng Tu (428934)

“…D) Hep3B proliferation rate assessed by MTT assay was significantly lower in rAd-p53 infected cells compared to control cells. E) Quantification of apoptotic cell population (AnnexinV positive/ PI negative) by flow cytometry. rAd-P53 infected Hep3B cells were composed of a larger subset of apoptotic cells after 72 hours of infection compared to control. …”

Yta4 decreases the affinity of Dnm1 for GTP. by Jiajia He (795335)

Six weeks of voluntary wheel running decreases 5-HT_2C mRNA expression in the amygdala. by Benjamin N. Greenwood (295216)

Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced degranulation. by Jian Hao (160736)

V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells. by Delphine Quélard (43727)

Anti-CXCR3 group decreased number of specific CD8⁺ T cells as well as polyfunctionality after infection with <i>T</i>. <i>cruzi</i>. by Camila Pontes Ferreira (6194006)

Figure 5 from TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma by Jessica D. Daley (22128489)

Oseltamivir treatment decreases the magnitude of the effector influenza-specific CD8⁺ T cell responses. by Nicola L. Bird (182542)

Decrease in fecundity with <i>PPR</i>. by Corinne Vacher (272363)

ATRA decreases mRNA expression of HO-1, GCLM and x-CT and lowers GSH level in BTZ-treated cells. by A. L. Furfaro (2587792)

The NK1-receptor antagonist ezlopitant significantly decreases the breakpoint for sucrose but not ethanol operant self-administration in rats. by Pia Steensland (362091)

“…<p>Ezlopitant (5 and 10 mg/kg i.p.) decreases the breakpoint for 5% sucrose using a PR schedule (<b>A</b>), but had no effect on the breakpoint for 10% ethanol (<b>B</b>). …”

Dose-dependent increase in NREM sleep and decrease in wakefulness by <i>p</i>.<i>o</i>. administration of TEG in mice. by Mahesh K. Kaushik (3753871)

“…<p>(A, B) Typical examples of EEG delta power (0.5–4 Hz), EMG integral, and hypnograms of a mouse after <i>p</i>.…”

ATRA decreases the binding of Nrf2 to ARE sequences in the promoter regions of HO-1, GCLM and x-CT in BTZ-treated cells. by A. L. Furfaro (2587792)

IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

Decrease in adhesion during early development of <i>Dictyostelium discoideum</i>. by Marco Tarantola (102609)

IRE1 depletion decreases heterochromatin, DNA, and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

EHD2 siRNA treated HUVEC showed decreased NO generation and cytosolic Ca²⁺ response. by Claudia Matthaeus (7485782)